We are live on ! Find out more
ANIK icon

Anika Therapeutics
ANIK

90 hedge funds and large institutions have $114M invested in Anika Therapeutics in 2013 Q2 according to their latest regulatory filings, with 90 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

49.3% more ownership

Funds ownership: 0% → 49.3% (+49%)

25% less call options, than puts

Call options by funds: $53K | Put options by funds: $71K

Holders
90
Holders Change
+90
Holders Change %
–
% of All Funds
2.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
90
Increased
–
Reduced
–
Closed
–
Calls
$53K
Puts
$71K
Net Calls
-$18K
Net Calls Change
-$18K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ANIK Hedge Fund Activity: Q2 2013 in Review

90 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q2 2013, worth a combined $114M.

Buyers outnumbered sellers: 90 funds opened new ANIK positions and 0 closed out — a net gain of 90 holders — while 0 added to existing stakes and 0 trimmed.

  • 90 institutional investors held Anika Therapeutics (ANIK) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $114M of Anika Therapeutics stock for Q2 2013.
  • 90 funds opened new Anika Therapeutics positions in Q2 2013 and 0 closed out, a net change of +90 holders.

Based on aggregated 13F filings for Q2 2013.